Isse les Moulineaux, France

Jerome Emile Georges Guillemont


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerome Emile Georges Guillemont: Innovator in Viral Infection Treatment

Introduction

Jerome Emile Georges Guillemont is a notable inventor based in Isse les Moulineaux, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of viral infections. His innovative work has led to the development of a unique patent that showcases his expertise and dedication to advancing medical research.

Latest Patents

Guillemont holds a patent for "1,2,4-triazine derivatives for the treatment of viral infections." This invention relates to 1,2,4-triazine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections. His work in this area has the potential to impact the treatment options available for various viral diseases.

Career Highlights

Throughout his career, Guillemont has been associated with prestigious institutions such as the Centre National De La Recherche Scientifique and the Université de Rouen. His roles in these organizations have allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Guillemont has worked alongside notable colleagues, including Vincent Gembus and Philippe Jubault. These collaborations have enriched his research and have been instrumental in the development of his patented innovations.

Conclusion

Jerome Emile Georges Guillemont is a distinguished inventor whose work in the field of viral infection treatment exemplifies innovation and dedication. His contributions continue to influence the pharmaceutical landscape, paving the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…